Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function.
Publication/Presentation Date
11-20-2013
Volume
169
Issue
5
First Page
84
Last Page
86
ISSN
1874-1754
Published In/Presented At
Patel, N. J., Hoosien, M., Deshmukh, A., Badheka, A. O., Grover, P. M., Shah, N., Singh, V., Mehta, K., Chothani, A., Savani, G. T., Arora, S., Bhalara, V., Patel, N., Khalpada, D., Rathod, A., Vazzana, T. J., Lafferty, J., Viles-Gonzalez, J. F., & Mitrani, R. D. (2013). Digoxin significantly improves all-cause mortality in atrial fibrillation patients with severely reduced left ventricular systolic function. International journal of cardiology, 169(5), e84–e86. https://doi.org/10.1016/j.ijcard.2013.10.040
Disciplines
Medicine and Health Sciences
PubMedID
24377111
Department(s)
Fellows and Residents
Document Type
Article
COinS